Related Experiment Video
Updated: Aug 7, 2026

10:30
Immunocompetent Alveolus-on-Chip Model for Studying Alveolar Mucosal Immune Responses
Published on: May 31, 2024
Breathing immunity into in vitro lung models
Ali Doryab1, Motaharehsadat Heydarian2, Clare Bryant2,3
1Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK ad2291@cam.ac.uk ac926@cam.ac.uk.
Thorax
|August 5, 2026
Summary
Developing advanced immune-competent lung models is crucial for understanding respiratory diseases and accelerating drug discovery. These models integrate immune cells into in vitro systems, overcoming limitations of current animal models for better clinical translation.
Area of Science:
- Immunology
- Respiratory Medicine
- Biotechnology
Background:
- The human lung possesses a specialized immune microenvironment vital for defense and repair.
- Existing animal models inadequately represent human immune pathways, hindering insights into respiratory diseases.
- Current in vitro lung models often lack immune components, limiting the study of host-immune interactions.
Purpose of the Study:
- To review the impact of immune-competent lung models on drug development and disease mechanisms.
- To explore future potential and technical challenges in integrating immune cells into in vitro lung models.
- To discuss strategies for maximizing the clinical relevance of these advanced models.
Main Methods:
- Review of existing literature on immune-competent lung models.
- Analysis of challenges in immune cell integration (viability, phenotype, recruitment).
- Exploration of biofabrication techniques (ECM, bioprinting, microvascular networks).
Main Results:
- Immune-competent lung models show significant impact on clinical drug development and mechanistic studies.
- Key challenges include maintaining immune cell function and ensuring microenvironmental compatibility.
- Biofabrication approaches enable physiologically relevant immune-resident lung cell interactions.
Conclusions:
- Advances in biofabrication and model development are paving the way for improved immune-competent lung models.
- These enhanced models promise to accelerate therapeutic discovery for respiratory diseases.
- Increased translational relevance of in vitro lung models is a key future outcome.

